Showing results (1311-1320 of 1,893) with videos related to

Sort By:
Pageof 190
Immunotherapy|February 13, 2023
Galectin-9 and PD-L1 antibody blockade combination therapy inhibits tumour progression in pancreatic cancerEnliang Li, Jian Xu, Qi Chen, et al.
Immunotherapy|March 6, 2023
Applications and current challenges of chimeric antigen receptor T cells in treating high-grade gliomas in adult and pediatric populationsNicolina Jovanovich, Ahmed Habib, Nu Farrukh Hameed, et al.
Immunotherapy|February 28, 2023
Combining in situ vaccination and immunogenic apoptosis to treat cancerArman Kalami, Mehdi Shahgolzari, Ahmad Yari Khosroushahi, et al.
Immunotherapy|February 28, 2023
An unusual case of immune-related gastritis in one patient receiving toripalimab therapyXiaoyan Chen, Wenjie Shi
Immunotherapy|August 4, 2016
Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin therapy in complicated primary antibody deficienciesMaria Giovanna Danieli, Federica Pulvirenti, Valeria Rocchi, et al.
Immunotherapy|November 7, 2022
Safety and efficacy analysis of PD-1 inhibitors in combination with chemotherapy for advanced pancreatic cancerDong Song, Xuejing Yang, Xin Guo, et al.
Immunotherapy|June 4, 2020
Tumor-infiltrating lymphocytes as a feasible adjuvant immunotherapy for osteosarcoma with a poor response to neoadjuvant chemotherapyJing Shi, Ming Li, Rongzhi Yang
Immunotherapy|March 23, 2023
Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantationKhalil Saleh, Ahmadreza Arbab, David Ghez, et al.
Immunotherapy|March 23, 2023
Updated insights on cardiac risks of CD19-directed chimeric antigen receptor T-cell therapy: a pharmacovigilance studyYinghong Zhai, Fangyuan Hu, Borui Zhu, et al.
Immunotherapy|August 21, 2025
Pure red cell aplasia due to Parvovirus B19 infection and atezolizumab: case report and literature reviewDante Pio Pallotta, Bernardo Stefanini, Agnese Pratelli, et al.
Pageof 190